115 related articles for article (PubMed ID: 22393376)
1. Effect of chronic escitalopram versus placebo on personality traits in healthy first-degree relatives of patients with depression: a randomized trial.
Knorr U; Vinberg M; Mortensen EL; Winkel P; Gluud C; Wetterslev J; Gether U; Kessing LV
PLoS One; 2012; 7(2):e31980. PubMed ID: 22393376
[TBL] [Abstract][Full Text] [Related]
2. Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial.
Robinson RG; Jorge RE; Moser DJ; Acion L; Solodkin A; Small SL; Fonzetti P; Hegel M; Arndt S
JAMA; 2008 May; 299(20):2391-400. PubMed ID: 18505948
[TBL] [Abstract][Full Text] [Related]
3. Personality change in a trial of psilocybin therapy v. escitalopram treatment for depression.
Weiss B; Ginige I; Shannon L; Giribaldi B; Murphy-Beiner A; Murphy R; Baker-Jones M; Martell J; Nutt DJ; Carhart-Harris RL; Erritzoe D
Psychol Med; 2024 Jan; 54(1):178-192. PubMed ID: 37264814
[TBL] [Abstract][Full Text] [Related]
4. Antidepressant study design affects patient expectancy: a pilot study.
Rutherford B; Sneed J; Devanand D; Eisenstadt R; Roose S
Psychol Med; 2010 May; 40(5):781-8. PubMed ID: 19732481
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of citalopram or escitalopram in patients with asthma and major depressive disorder.
Agarwal CD; Palka JM; Gajewski AJ; Khan DA; Brown ES
Ann Allergy Asthma Immunol; 2024 Mar; 132(3):374-382. PubMed ID: 37952772
[TBL] [Abstract][Full Text] [Related]
6. Placebo response of non-pharmacological and pharmacological trials in major depression: a systematic review and meta-analysis.
Brunoni AR; Lopes M; Kaptchuk TJ; Fregni F
PLoS One; 2009; 4(3):e4824. PubMed ID: 19293925
[TBL] [Abstract][Full Text] [Related]
7. Personality traits predict treatment outcome of an antidepressant in untreated adolescents with depression: An 8-week, open-label, flexible-dose study.
Ran LY; Liu XY; Wang W; Tao WQ; Xiang JJ; Zeng Q; Kong YT; Zhang CY; Liao J; Qiu HT; Kuang L
J Affect Disord; 2024 Apr; 350():102-109. PubMed ID: 38199422
[TBL] [Abstract][Full Text] [Related]
8. Effects of psilocybin therapy on personality structure.
Erritzoe D; Roseman L; Nour MM; MacLean K; Kaelen M; Nutt DJ; Carhart-Harris RL
Acta Psychiatr Scand; 2018 Nov; 138(5):368-378. PubMed ID: 29923178
[TBL] [Abstract][Full Text] [Related]
9. The influence of media use degree on public depressive symptoms: mediating role of big five personality.
Gong F; Jia Y; Sun X; Min H; Jia X; Wang F; Huang X; Lin X; Li Z; Wu Y
BMC Psychiatry; 2023 Aug; 23(1):616. PubMed ID: 37608360
[TBL] [Abstract][Full Text] [Related]
10. SNP-based heritability estimates of the personality dimensions and polygenic prediction of both neuroticism and major depression: findings from CONVERGE.
Docherty AR; Moscati A; Peterson R; Edwards AC; Adkins DE; Bacanu SA; Bigdeli TB; Webb BT; Flint J; Kendler KS
Transl Psychiatry; 2016 Oct; 6(10):e926. PubMed ID: 27779626
[TBL] [Abstract][Full Text] [Related]
11. 'Personality and bipolar disorder: personality profiles of patients with remitted bipolar disorder and matched controls in a Danish sample'.
Seeberg Nielsen L; Krarup Larsen S; Csillag C; Mortensen EL; Vinberg M
Nord J Psychiatry; 2023 Oct; 77(7):661-668. PubMed ID: 37191348
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effect of increased openness: Investigating mechanism of action in MDMA-assisted psychotherapy.
Wagner MT; Mithoefer MC; Mithoefer AT; MacAulay RK; Jerome L; Yazar-Klosinski B; Doblin R
J Psychopharmacol; 2017 Aug; 31(8):967-974. PubMed ID: 28635375
[TBL] [Abstract][Full Text] [Related]
13. Multiple sclerosis and personality traits: associations with depression and anxiety.
Vaheb S; Mokary Y; Yazdan Panah M; Shaygannejad A; Afshari-Safavi A; Ghasemi M; Shaygannejad V; Moases Ghaffary E; Mirmosayyeb O
Eur J Med Res; 2024 Mar; 29(1):171. PubMed ID: 38475891
[TBL] [Abstract][Full Text] [Related]
14. Effects of escitalopram on synaptic density in the healthy human brain: a randomized controlled trial.
Johansen A; Armand S; Plavén-Sigray P; Nasser A; Ozenne B; Petersen IN; Keller SH; Madsen J; Beliveau V; Møller K; Vassilieva A; Langley C; Svarer C; Stenbæk DS; Sahakian BJ; Knudsen GM
Mol Psychiatry; 2023 Oct; 28(10):4272-4279. PubMed ID: 37814129
[TBL] [Abstract][Full Text] [Related]
15. White matter abnormalities predict residual negative self-referential thinking following treatment of late-life depression with escitalopram: A preliminary study.
Victoria LW; Alexopoulos GS; Ilieva I; Stein AT; Hoptman MJ; Chowdhury N; Respino M; Morimoto SS; Kanellopoulos D; Avari JN; Gunning FM
J Affect Disord; 2019 Jan; 243():62-69. PubMed ID: 30236759
[TBL] [Abstract][Full Text] [Related]
16. Personality predicting relapse: A facet analysis of the NEO PI-R.
Faltushanskiy Z; Herrold AA; Werby J; Betteridge EM; Angres D
Am J Addict; 2024 Jan; 33(1):58-64. PubMed ID: 37667561
[TBL] [Abstract][Full Text] [Related]
17. Interactions between neuroticism and stressful life events predict response to pharmacotherapy for major depression: A CAN-BIND 1 report.
Allen TA; Harkness KL; Lam RW; Milev R; Frey BN; Mueller DJ; Uher R; Kennedy SH; Quilty LC
Personal Ment Health; 2021 Nov; 15(4):273-282. PubMed ID: 34008342
[TBL] [Abstract][Full Text] [Related]
18. Personality traits as predictors of recovery among patients with substance use disorder.
Fodstad EC; Erga AH; Pallesen S; Ushakova A; Erevik EK
J Subst Use Addict Treat; 2024 Jul; 162():209360. PubMed ID: 38631658
[TBL] [Abstract][Full Text] [Related]
19. Associations Between a General Factor and Group Factor from the Spanish-Language Eysenck Personality Questionnaire-Revised Short Form's Neuroticism Scale and the Revised NEO Personality Inventory Domains and Facets.
Weiss A; Luciano M; Aluja A
J Pers Assess; 2024 Mar; ():1-11. PubMed ID: 38457531
[TBL] [Abstract][Full Text] [Related]
20. Personality traits and eating habits in a large sample of Estonians.
Mõttus R; Realo A; Allik J; Deary IJ; Esko T; Metspalu A
Health Psychol; 2012 Nov; 31(6):806-14. PubMed ID: 22268715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
